XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]        
Revenue $ 261,176 $ 231,663 $ 761,903 $ 606,277
Costs and expenses:        
Cost of revenue 47,627 41,110 136,701 115,829
Research and development 40,869 33,004 119,618 89,886
Selling, general and administrative 107,618 86,198 313,881 233,809
Acquired in-process research and development 496   115,986  
Costs and Expenses, Total 196,610 160,312 686,186 439,524
Operating income 64,566 71,351 75,717 166,753
Other (loss) income:        
Investment income, net 891 1,449 2,918 5,668
Other (loss) income, net (7,580) 7,935 37,163 42,305
Nonoperating Income (Expense), Total (6,689) 9,384 40,081 47,973
Income before income taxes 57,877 80,735 115,798 214,726
Income tax provision 12,125 18,867 39,618 46,057
Net income $ 45,752 $ 61,868 $ 76,180 $ 168,669
Net income per share - basic $ 1.01 $ 1.37 $ 1.68 $ 3.74
Weighted average shares outstanding - basic 45,508 45,201 45,419 45,105
Net income per share - diluted $ 1.00 $ 1.35 $ 1.66 $ 3.69
Weighted average shares outstanding - diluted 45,921 45,706 45,851 45,653